Furthermore, the promoter of the CYP39A1 gene was hypermethylated in ovarian cancer, resulting in its transcriptional disorder, which caused metabolic disorders of cholesterol and quinoline acid and contributed to the occurrence of ovarian cancer [43]. This evidence concerns the gene CYP39A1 and metabolic disease.